# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Craig-Hallum analyst Anthony Stoss maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $20 to $15.
Enovix said quarterly sales came in at $5.272 million, beating the analyst consensus estimate of $3.779 million by 39.53% and r...
Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase a...
Enovix reports quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 29 cents by 6.9%.